Adjuvant Therapy-Related Shortening of Survival (ATRESS): An Underrated Phenomenon

Authors :: Stefan Bartels
Ulrich R. Kleeberg
Michael K. Fink
Source :: The Oncologist. 20:88-88
Publication Year :: 2014
Publisher :: Oxford University Press (OUP), 2014.
Abstract: Shortening of survival after dissemination following adjuvant treatment is not understood well enough and is difficult to search for in public databases because of the lack of specific search terms. We suggest using the acronym ATRESS, for “adjuvant therapy-related shortening of survival,” in future literature concerning this issue.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Surgery
chemistry.chemical_compound
Search terms
chemistry
Fluorouracil
Internal medicine
Adjuvant therapy
Medicine
Deoxycytidine
Letters to the Editor
business
Adjuvant
medicine.drug

Full Text Access

Tools